Glycosylation products as toxic mediators of diabetic complications.

Hyperglycemia causes excessive amounts of irreversible advanced glycosylation end products (AGEPs) to accumulate on long-lived extracellular matrix proteins and probably also on DNA in tissues that develop diabetic complications. AGEPs induce permanent abnormalities in extracellular protein cross-linking, cell-matrix interactions, and DNA structure in vitro. Pharmacologically inhibiting AGEP formation in long-term diabetic animals prevents both retinal capillary pathology and thickening of the glomerular basement membrane.

[1]  S. Klahr,et al.  Progression of renal disease. , 1988, Seminars in nephrology.

[2]  A. Cerami,et al.  Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. , 1988, The New England journal of medicine.

[3]  Mara,et al.  High glucose induces DNA damage in cultured human endothelial cells. , 1986, The Journal of clinical investigation.

[4]  K. Nicholls,et al.  Advanced glycosylation end-products in experimental murine diabetic nephropathy: effect of islet isografting and of aminoguanidine. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[5]  H. Gerlach,et al.  Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties , 1989, The Journal of experimental medicine.

[6]  A. Cerami,et al.  Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. , 1986, Science.

[7]  E. Tsilibary,et al.  Laminin Alterations After In Vitro Nonenzymatic Glycosylation , 1990, Diabetes.

[8]  J. Olerud,et al.  A method for localizing the early products of nonenzymatic glycosylation in fixed tissue. , 1989, Journal of Investigative Dermatology.

[9]  E. Tsilibary,et al.  The effect of nonenzymatic glucosylation on the binding of the main noncollagenous NC1 domain to type IV collagen. , 1988, The Journal of biological chemistry.

[10]  E. Eikenberry,et al.  Glycation induces expansion of the molecular packing of collagen. , 1988, Journal of molecular biology.

[11]  A. Cerami,et al.  Nonenzymatic Glycosylation Products on Collagen Covalently Trap Low-Density Lipoprotein , 1985, Diabetes.

[12]  K. Manogue,et al.  Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. , 1988, Science.

[13]  M. Sporn,et al.  A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-β , 1988, Cell.